US Stock MarketDetailed Quotes

Oruka Therapeutics (ORKA)

Watchlist
  • 69.030
  • +1.290+1.90%
Close Apr 24 15:59 ET
  • 69.030
  • 0.0000.00%
Post 20:01 ET
3.47BMarket Cap-37.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oruka Therapeutics (ORKA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
122.05M
34.43M
15.81%34.11M
32.27%28.43M
265.53%25.09M
29.45M
21.49M
6.86M
Selling and administrative expenses
--21.41M
--6.79M
36.16%5.12M
53.97%4.34M
209.04%5.16M
--3.76M
--2.82M
--1.67M
-General and administrative expense
--21.41M
--6.79M
36.16%5.12M
53.97%4.34M
209.04%5.16M
--3.76M
--2.82M
--1.67M
Research and development costs
--100.64M
--27.64M
12.83%28.99M
28.99%24.09M
283.69%19.93M
--25.69M
--18.67M
--5.19M
Operating profit
-122.05M
-34.43M
-15.81%-34.11M
-32.27%-28.43M
-265.53%-25.09M
-29.45M
-21.49M
-6.86M
Net non-operating interest income expense
16.63M
4.85M
363.92%3.83M
614.27%3.86M
2,012.15%4.09M
826K
-750K
-214K
Non-operating interest income
--16.63M
--4.85M
188.12%3.83M
--3.86M
--4.09M
--1.33M
--0
--0
Non-operating interest expense
--0
--0
--0
--0
--0
--504K
--750K
--214K
Other net income (expense)
-12K
-1K
-4K
-2K
-5K
Other non- operating income (expenses)
---12K
---1K
---4K
---2K
---5K
----
----
----
Income before tax
-105.43M
-29.58M
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Income tax
Net income
-105.43M
-29.58M
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Net income continuous Operations
---105.43M
---29.58M
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
---28.62M
---22.24M
---7.08M
Minority interest income
Net income attributable to the parent company
-105.43M
-29.58M
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-105.43M
-29.58M
-5.78%-30.28M
-10.48%-24.57M
-196.72%-21M
-28.62M
-22.24M
-7.08M
Basic earnings per share
-1.85
-0.45
62.33%-0.55
39.20%-0.46
-66.16%-0.4
-1.46
-0.7566
-0.2407
Diluted earnings per share
-1.85
-0.45
62.33%-0.55
39.20%-0.46
-66.16%-0.4
-1.46
-0.7566
-0.2407
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 122.05M34.43M15.81%34.11M32.27%28.43M265.53%25.09M29.45M21.49M6.86M
Selling and administrative expenses --21.41M--6.79M36.16%5.12M53.97%4.34M209.04%5.16M--3.76M--2.82M--1.67M
-General and administrative expense --21.41M--6.79M36.16%5.12M53.97%4.34M209.04%5.16M--3.76M--2.82M--1.67M
Research and development costs --100.64M--27.64M12.83%28.99M28.99%24.09M283.69%19.93M--25.69M--18.67M--5.19M
Operating profit -122.05M-34.43M-15.81%-34.11M-32.27%-28.43M-265.53%-25.09M-29.45M-21.49M-6.86M
Net non-operating interest income expense 16.63M4.85M363.92%3.83M614.27%3.86M2,012.15%4.09M826K-750K-214K
Non-operating interest income --16.63M--4.85M188.12%3.83M--3.86M--4.09M--1.33M--0--0
Non-operating interest expense --0--0--0--0--0--504K--750K--214K
Other net income (expense) -12K-1K-4K-2K-5K
Other non- operating income (expenses) ---12K---1K---4K---2K---5K------------
Income before tax -105.43M-29.58M-5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Income tax
Net income -105.43M-29.58M-5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Net income continuous Operations ---105.43M---29.58M-5.78%-30.28M-10.48%-24.57M-196.72%-21M---28.62M---22.24M---7.08M
Minority interest income
Net income attributable to the parent company -105.43M-29.58M-5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -105.43M-29.58M-5.78%-30.28M-10.48%-24.57M-196.72%-21M-28.62M-22.24M-7.08M
Basic earnings per share -1.85-0.4562.33%-0.5539.20%-0.46-66.16%-0.4-1.46-0.7566-0.2407
Diluted earnings per share -1.85-0.4562.33%-0.5539.20%-0.46-66.16%-0.4-1.46-0.7566-0.2407
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -